再鼎医药

最新新闻

• U.S. Stocks Move | Zai Lab (ZLAB.US) Surges Over 12% as Q2 Product Revenue Rises 11% Sequentially
  Zhitong Finance · 2026/8/6
• 评级变动
  Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $37
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• 评级变动
  Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $53
  \u5e02\u573a\u8d44\u8baf · 2026/2/23
• 评级变动
  Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $27
  \u5e02\u573a\u8d44\u8baf · 2026/5/23
• 评级变动
  J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $39
  \u5e02\u573a\u8d44\u8baf · 2026/2/5
• US Stock Movement | Shares Surge for Two Consecutive Days! Zai Lab (ZLAB.US) Rises Over 10%
  Zhitong Finance · 2026/8/7
• 评级变动
  Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $47
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• 评级变动
  J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/4/21
• 评级变动
  Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $44
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)
  TipRanks · 2026/9/2
• J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $36
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $47
  \u5e02\u573a\u8d44\u8baf · 2026/3/10
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)
  TipRanks · 2026/3/26
• 评级变动
  J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/3/26
• 评级变动
  BofA Securities Maintains Zai Lab(ZLAB.US) With Hold Rating, Cuts Target Price to $21.8
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $36
  \u5e02\u573a\u8d44\u8baf · 2026/8/27
• 评级变动
  J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $32
  \u5e02\u573a\u8d44\u8baf · 2026/3/18
• 评级变动
  Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $53
  \u5e02\u573a\u8d44\u8baf · 2026/2/20

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。